Glenmark Pharmaceuticals informs about media release

25 Jan 2024 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release today titled ‘Jiangsu Alphamab Biopharmaceuticals, 3D Medicines (Beijing) and Glenmark announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2036.00 6.40 (0.32%)
31-Dec-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1272.00
Cipla 1507.30
Zydus Lifesciences 912.75
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×